Acute and impaired wound healing: Pathophysiology and current methods for drug delivery, part 1: Normal and chronic wounds: Biology, causes, and approaches to care

Advances in Skin and Wound Care

Volumn 25, Issue 7, 2012, Pages 304-314

  Demidova Rice, Tatiana N ^a   Hamblin, Michael R ^a   Herman, Ira M ^b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Acute wound healing; Drug delivery and wounds; Wound care strategies

Indexed keywords

ANTIINFECTIVE AGENT; SIGNAL PEPTIDE;

BIOFILM; CHRONIC DISEASE; CLASSIFICATION; DEBRIDEMENT; GENETICS; GROWTH, DEVELOPMENT AND AGING; HUMAN; INJURY; KERATINOCYTE; METABOLISM; METHODOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW; WOUND HEALING;

ANTI-INFECTIVE AGENTS; BIOFILMS; CHRONIC DISEASE; DEBRIDEMENT; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; KERATINOCYTES; WOUND HEALING; WOUNDS AND INJURIES;

EID: 84863697732     PISSN: 15277941     EISSN: 15388654     Source Type: Journal    
DOI: 10.1097/01.ASW.0000416006.55218.d0     Document Type: Review

References (96)

1. Singer AJ, Dagum AB. Current management of acute cutaneous wounds. N Engl J Med 2008;359:1037-46.
2. Hostetler SG, Xiang H, Gupta S, Sen C, Gordillo JM. Discharge patterns of injury-related hospitalizations with an acute wound in the United States. Wounds 2006;18:340-51.
3. Singer AJ, Clark RA. Cutaneous wound healing. N Engl J Med 1999;341:738-46. (Pubitemid 29407375)
4. Falanga V. Wound healing and its impairment in the diabetic foot. Lancet 2005;366:1736-43. (Pubitemid 41587454)
5. Weyrich AS, Zimmerman GA. Platelets: signaling cells in the immune continuum. Trends Immunol 2004;25:489-95. (Pubitemid 39490256)
6. Gilroy DW, Lawrence T, Perretti M, Rossi AG. Inflammatory resolution: new opportunities for drug discovery. Nat Rev Drug Discov 2004;3:401-16. (Pubitemid 38618123)
7. Eming SA, Krieg T, Davidson JM. Inflammation in wound repair: molecular and cellular mechanisms. J Invest Dermatol 2007;127:514-25.
8. Humar R, Kiefer FN, Berns H, Resink TJ, Battegay EJ. Hypoxia enhances vascular cell proliferation and angiogenesis in vitro via rapamycin (mTOR)-dependent signaling. FASEB J 2002;16:771-80. (Pubitemid 34615125)
9. Folkman J, Klagsbrun M. Angiogenic factors. Science 1987;235:442-7. (Pubitemid 17009577)
10. Asahara T, Murohara T, Sullivan A, et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997;275:964-7. (Pubitemid 27087709)
11. Liu ZJ, Velazquez OC. Hyperoxia, endothelial progenitor cell mobilization, and diabetic wound healing. Antioxid Redox Signal 2008;10:1869-82.
12. Leone AM, Valgimigli M, Giannico MB, et al. From bone marrow to the arterial wall: the ongoing tale of endothelial progenitor cells. Eur Heart J 2009;30(8):890-9.
13. Maeng YS, Choi HJ, Kwon JY, et al. Endothelial progenitor cell homing: prominent role of the IGF2-IGF2R-PLCbeta2 axis. Blood 2009;113:233-43.
14. Gallagher KA, Liu ZJ, Xiao M, et al. Diabetic impairments in NO-mediated endothelial progenitor cell mobilization and homing are reversed by hyperoxia and SDF-1 alpha. 2007;117: 1249-59.
15. Hinz B. Formation and function of the myofibroblast during tissue repair. J Invest Dermatol 2007;127:526-37.
16. Ehrlich HP, Keefer KA, Myers RL, Passaniti A. Vanadate and the absence of myofibroblasts in wound contraction. Arch Surg 1999;134:494-501. (Pubitemid 29218120)
17. Rai NK, Tripathi K, Sharma D, Shukla VK. Apoptosis: a basic physiologic process in wound healing. Int J Low Extrem Wounds 2005;4:138-44. (Pubitemid 41437580)
18. Desmouliere A, Redard M, Darby I, Gabbiani G. Apoptosis mediates the decrease incellularity during the transition between granulation tissue and scar. Am J Pathol 1995;146:56-66.
19. Akasaka Y, Ono I, Yamashita T, Jimbow K, Ishii T. Basic fibroblast growth factor promotes apoptosis and suppresses granulation tissue formation in acute incisional wounds. J Pathol 2004;203:710-20. (Pubitemid 38714109)
20. Seifert O, Mrowietz U. Keloid scarring: bench and bedside. Arch Dermatol Res 2009;301: 259-72.
21. Gosain A, DiPietro LA. Aging and wound healing. World J Surg 2004;28:321-6. (Pubitemid 38375537)
22. Narayan KMV, Boyle JP, Thompson TJ, Sorensen SW, Williamson DF. Lifetime risk for diabetes mellitus in the United States. JAMA 2003;290:1884-90. (Pubitemid 37430605)
23. Ramsey SD, Newton K, Blough D, et al. Incidence, outcomes, and cost of foot ulcers in patients with diabetes. Diabetes Care 1999;22:382-7. (Pubitemid 29106890)
24. Bitsch M, Saunte DM, Lohmann M, Holstein PE, Jorgensen B, Gottrup F. Standardised method of surgical treatment of chronic leg ulcers. Scand J Plast Reconstr Surg Hand Surg 2005;39:162-9. (Pubitemid 40868428)
25. Shai A, Halevy S. Direct triggers for ulceration in patients with venous insufficiency. Int J Dermatol 2005;44:1006-9. (Pubitemid 43046118)
26. Edwards R, Harding KG. Bacteria and wound healing. Curr Opin Infect Dis 2004;17(2):91-6. (Pubitemid 38453386)
27. Wolcott RD, Rhoads DD, Dowd SE. Biofilms and chronic wound inflammation. J Wound Care 2008;17:333-41.
28. Pardes JB, Takagi H, Martin TA, Ochoa MS, Falanga V. Decreased levels of alpha 1(I) procollagen mRNA in dermal fibroblasts grown on fibrin gels and in response to fibrinopeptide B. J Cell Physiol 1995;162(1):9-14.
29. Higley HR, Ksander GA, Gerhardt CO, Falanga V. Extravasation of macromolecules and possible trapping of transforming growth factor-beta in venous ulceration. Br J Dermatol 1995;132:79-85.
30. Walker DJ. Venous stasis wounds. Orthop Nurs 1999;18(5):65-74, 95.
31. Kobrin KL, Thompson PJ, van de Scheur M, Kwak TH, Kim S, Falanga V. Evaluation of dermal pericapillary fibrin cuffs in venous ulceration using confocal microscopy. Wound Repair Regen 2008;16:503-6. (Pubitemid 352000315)
32. Bonham PA. Assessment and management of patients with venous, arterial, and diabetic/neuropathic lower extremity wounds. AACN Clin Issues 2003;14:442-56.
33. Sieggreen MY, Kline RA. Arterial insufficiency and ulceration: diagnosis and treatment options. Nurse Pract 2004;29(9):46-52.
34. Grey JE, Harding KG, Enoch S. Venous and arterial leg ulcers. BMJ 2006;332:347-50. (Pubitemid 43253753)
35. Defloor T. The risk of pressure sores: a conceptual scheme. J Clin Nurs 1999;8:206-16.
36. Ben-Porath I, Weinberg RA. The signals and pathways activating cellular senescence. Int J Biochem Cell Biol 2005;37:961-76. (Pubitemid 40311739)
37. Mast BA, Schultz GS. Interactions of cytokines, growth factors, and proteases in acute and chronic wounds. Wound Repair Regen 1996;4:411-20. (Pubitemid 126670858)
38. Lauer G, Sollberg S, Cole M, et al. Expression and proteolysis of vascular endothelial growth factor is increased in chronic wounds. J Invest Dermatol 2000;115(1):12-8. (Pubitemid 30470185)
39. Loot MA, Kenter SB, Au FL, et al. Fibroblasts derived from chronic diabetic ulcers differ in their response to stimulation with EGF, IGF-I, bFGF and PDGF-AB compared to controls. Eur J Cell Biol 2002;81:153-60. (Pubitemid 34308679)
40. Seidman C, Raffetto JD, Marien B, Kroon C, Seah CC, Menzoian JO. bFGF-induced alterations in cellular markers of senescence in growth-rescued fibroblasts from chronic venous ulcer and venous reflux patients. Ann Vasc Surg 2003;17:239-44. (Pubitemid 36687571)
41. Vasquez R, Marien BJ, Gram C, Goodwin DG, Menzoian JO, Raffetto JD. Proliferative capacity of venous ulcer wound fibroblasts in the presence of platelet-derived growth factor. Vasc Endovascular Surg 2004;38:355-60. (Pubitemid 39079941)
42. Raffetto JD, Mendez MV, Marien BJ, et al. Changes in cellular motility and cytoskeletal actin in fibroblasts from patients with chronic venous insufficiency and in neonatal fibroblasts in the presence of chronic wound fluid. J Vasc Surg 2001;33:1233-41.
43. Lerman OZ, Galiano RD, Armour M, Levine JP, Gurtner GC. Cellular dysfunction in the diabetic fibroblast: impairment in migration, vascular endothelial growth factor production, and response to hypoxia. Am J Pathol 2003;162:303-12. (Pubitemid 36042012)
44. Usui ML, Mansbridge JN, Carter WG, Fujita M, Olerud JE. Keratinocyte migration, proliferation, and differentiation in chronic ulcers from patients with diabetes and normal wounds. J Histochem Cytochem 2008;56:687-96. (Pubitemid 351842422)
45. Stojadinovic O, Pastar I, Vukelic S, et al. Deregulation of keratinocyte differentiation and activation: a hallmark of venous ulcers. J Cell Mol Med 2008;12(6B):2675-90.
46. Stojadinovic O, Brem H, Vouthounis C, et al. Molecular pathogenesis of chronic wounds: the role of beta-catenin and c-myc in the inhibition of epithelialization and wound healing. Am J Pathol 2005;167:59-69. (Pubitemid 40884770)
47. Muller M, Essin K, Hill K, et al. Specific TRPC6 channel activation, a novel approach to stimulate keratinocyte differentiation. J Biol Chem 2008;283:33942-54.
48. Okwueze MI, Cardwell NL, Pollins AC, Nanney LB. Modulation of porcine wound repair with a transfected ErbB3 gene and relevant EGF-like ligands. J Invest Dermatol 2007;127:1030-41. (Pubitemid 46625131)
49. Loots MA, Lamme EN, Zeegelaar J, Mekkes JR, Bos JD, Middelkoop E. Differences in cellular infiltrate and extracellular matrix of chronic diabetic and venous ulcers versus acute wounds. J Invest Dermatol 1998;111:850-7. (Pubitemid 28509329)
50. Agren MS, Steenfos HH, Dabelsteen S, Hansen JB, Dabelsteen E. Proliferation and mitogenic response to PDGF-BB of fibroblasts isolated from chronic venous leg ulcers is ulcer-age dependent. J Invest Dermatol 1999;112:463-9. (Pubitemid 29171936)
51. Kuo PC, Kao CH, Chen JK. Glycated type 1 collagen induces endothelial dysfunction in culture. In Vitro Cell Dev Biol Anim 2007;43:338-43.
52. Reigle KL, Di Lullo G, Turner KR, et al. Non-enzymatic glycation of type I collagen diminishes collagen-proteoglycan binding and weakens cell adhesion. J Cell Biochem 2008;104: 1684-98.
53. Liao H, Zakhaleva J, Chen W. Cells and tissue interactions with glycated collagen and their relevance to delayed diabetic wound healing. Biomaterials 2009;30:1689-96.
54. Death AK, Fisher EJ, McGrath KC, Yue DK. High glucose alters matrix metalloproteinase expression in two key vascular cells: potential impact on atherosclerosis in diabetes. Atherosclerosis 2003;168:263-9. (Pubitemid 36703325)
55. Lee SJ, Bae SS, Kim KH, et al. High glucose enhances MMP-2 production in adventitial fibroblasts via Akt1-dependent NF-kappaB pathway. FEBS Lett 2007;581:4189-94. (Pubitemid 47301852)
56. Dalton SJ, Whiting CV, Bailey JR, Mitchell DC, Tarlton JF. Mechanisms of chronic skin ulceration linking lactate, transforming growth factor-beta, vascular endothelial growth factor, collagen remodeling, collagen stability, and defective angiogenesis. J Invest Dermatol 2007;127:958-68. (Pubitemid 46434662)
57. Lobmann R, Zemlin C, Motzkau M, Reschke K, Lehnert H. Expression of matrix metalloproteinases and growth factors in diabetic foot wounds treated with a protease absorbent dressing. J Diabetes Complications 2006;20:329-35. (Pubitemid 44308585)
58. Rayment EA, Dargaville TR, Shooter GK, George GA, Upton Z. Attenuation of protease activity in chronic wound fluid with bisphosphonate-functionalised hydrogels. Biomaterials 2008;29: 1785-95.
59. Bader MS. Diabetic foot infection. Am Fam Physician 2008;78(1):71-9.
60. Ovington L. Bacterial toxins and wound healing. Ostomy Wound Manage 2003;49(7A Suppl): 8-12.
61. James GA, Swogger E, Wolcott R, et al. Biofilms in chronic wounds. Wound Repair Regen 2008;16(1):37-44.
62. Martin JM, Zenilman JM, Lazarus GS. Molecular microbiology: new dimensions for cutaneous biology and wound healing. J Invest Dermatol 2009;130:38-48.
63. Clark F. Schierle, Mauricio De la Garza, Thomas A. Mustoe, Robert D. Galiano. Staphylococcal biofilms impair wound healing by delaying reepithelialization in a murine cutaneous wound model. Wound Repair Regen 2009;17:354-9.
64. Cirioni O, Ghiselli R, Minardi D, et al. RNAIII-inhibiting peptide affects biofilm formation in a rat model of staphylococcal ureteral stent infection. Antimicrob Agents Chemother 2007; 51:4518-20. (Pubitemid 350209919)
65. Schultz GS, Sibbald RG, Falanga V, et al. Wound bed preparation: a systematic approach to wound management. Wound Repair Regen 2003;11(Suppl 1):S1-28.
66. Tomic-Canic M, Ayello EA, Stojadinovic O, Golinko MS, Brem H. Using gene transcription patterns (bar coding scans) to guide wound debridement and healing. Adv Skin Wound Care 2008;21:487-92.
67. Ayello EA, Cuddigan JE. Debridement: controlling the necrotic/cellular burden. Adv Skin Wound Care 2004;17:66-75.
68. Attinger CE, Janis JE, Steinberg J, Schwartz J, Al-Attar A, Couch K. Clinical approach to wounds: debridement and wound bed preparation including the use of dressings and wound-healing adjuvants. Plast Reconstr Surg 2006;117(7 Suppl):72S-109S. (Pubitemid 44317773)
69. Turkmen A, Graham K, McGrouther DA. Therapeutic applications of the larvae for wound debridement. J Plast Reconstr Aesthet Surg 2009;63:184-8.
70. Riley KN, Herman IM. Collagenase promotes the cellular responses to injury and wound healing in vivo. J Burns Wounds 2005;4:e8.
71. Food and Drug Administration. FDA warns companies to stop marketing unapproved ophthalmic balanced salt solution drug products and topical drug products containing papain. September 23, 2008. http://www.fda.gov/NewsEvents/ Newsroom/PressAnnouncements/2008/ucm116956.htm?utm-source=fdaSearch&utm- medium=website&utm-term=papain&utm-content=5. Last accessed April 13, 2012.
72. Mandl I. Bacterial collagenases and their clinical applications. Arzneimittelforschung 1982; 32(10a):1381-4. (Pubitemid 12006760)
73. Postlethwaite AE, Kang AH. Collagen-and collagen peptide-induced chemotaxis of human blood monocytes. J Exp Med 1976;143:1299-1307.
74. Postlethwaite AE, Seyer JM, Kang AH. Chemotactic attraction of human fibroblasts to type I, II, and III collagens and collagen-derived peptides. Proc Natl Acad Sci U S A 1978;75(2): 871-5. (Pubitemid 8319476)
75. Herman IM. Molecular mechanisms regulating the vascular endothelial cell motile response to injury. J Cardiovasc Pharmacol 1993;22(Suppl 4):S25-36. (Pubitemid 23329998)
76. Herman IM. Stimulation of human keratinocyte migration and proliferation in vitro: insights into the cellular responses to injury and wound healing. Wounds 1996;8:33-42.
77. Radice M, Brun P, Bernardi D, Fontana C, Cortivo R, Abatangelo G. Clostridial collagenase releases bioactive fragments from extracellular matrix molecules. J Burn Care Rehabil 1999; 20:282-91. (Pubitemid 29340652)
78. Demidova-Rice TN, Herman IM. Identification and characterization of novel wound-healing peptides derived from extracellular matrices. Abstracts of 19th Annual Meeting of the Wound Healing Society SAWC/WHS Joint Meeting. Wound Rep Regen 2009;17(2):A22.
79. Shi L, Ermis R, Garcia T, Telgenhoff D, Aust D. Abstracts of 19th Annual Meeting of the Wound Healing Society SAWC/WHS Joint Meeting. Wound Rep Regen 2009;17(2):A34.
80. Demidova-Rice TN, Geevarghese A, Herman IM. Bioactive peptides derived from vascular endothelial cell extracellular matrices promote microvascular morphogenesis and wound healing in vitro. Wound Repair Regen 2011;19:59-70.
81. Falanga V. Wound bed preparation and the role of enzymes: a case for multiple actions of the therapeutic agents. Wounds 2002;14:47-57.
82. Ramundo J, Gray M. Enzymatic wound debridement. J Wound Ostomy Continence Nurs 2008;35:273-80.
83. Rosenberg L, Lapid O, Bogdanov-Berezovsky A, et al. Safety and efficacy of a proteolytic enzyme for enzymatic burn debridement: a preliminary report. Burns 2004;30: 843-50. (Pubitemid 39536054)
84. Foti C, Conserva A, Casulli C, Scrimieri V, Pepe ML, Quaranta D. Contact dermatitis with clostridiopeptidase A contained in Noruxol ointment. Contact Dermatitis 2007;56:361-2. (Pubitemid 46934344)
85. Tam CC, Elston DM. Allergic contact dermatitis caused by white petrolatum on damaged skin. Dermatitis 2006;17:201-3. (Pubitemid 46155312)
86. Mekkes JR, Zeegelaar JE, Westerhof W. Quantitative and objective evaluation of wound debriding properties of collagenase and fibrinolysin/ desoxyribonuclease in a necrotic ulcer animal model. Arch Dermatol Res 1998;290:152-7. (Pubitemid 28143368)
87. Metzmacher I, Ruth P, Abel M, Friess W. In vitro binding of matrix metalloproteinase-2 (MMP-2), MMP-9, and bacterial collagenase on collagenous wound dressings. Wound Repair Regen 2007;15:549-55. (Pubitemid 47087648)
88. Payne WG, Salas RE, Ko F, et al. Enzymatic debriding agents are safe in wounds with high bacterial bioburdens and stimulate healing. Eplasty 2008;8:e17.
89. Howell-Jones RS, Wilson MJ, Hill KE, Howard AJ, Price PE, Thomas DW. A review of the microbiology, antibiotic usage and resistance in chronic skin wounds. J Antimicrob Chemother 2005;55:143-9. (Pubitemid 40331137)
90. Lipsky BA. New developments in diagnosing and treating diabetic foot infections. Diabetes Metab Res Rev 2008;24(Suppl 1):S66-71. (Pubitemid 351802774)
91. Imegwu O, Chang TH, Steinberg JJ. Staphylococcus aureus peptidoglycan ameliorates cyclophosphamide-induced impairment of wound healing. Wound Repair Regen 1997;5: 364-72. (Pubitemid 127689598)
92. Levenson SM, Kan-Gruber D, Gruber C, Molnar J, Seifter E. Wound healing accelerated by Staphylococcus aureus. Arch Surg 1983;118:310-20. (Pubitemid 13195793)
93. Di Poto A, Sbarra MS, Provenza G, Visai L, Speziale P. The effect of photodynamic treatment combined with antibiotic action or host defence mechanisms on Staphylococcus aureus biofilms. Biomaterials 2009;30:3158-66.
94. Etufugh CN, Phillips TJ. Venous ulcers. Clin Dermatol 2007;25:121-30. (Pubitemid 46177457)
95. Reiber GE. Diabetic foot care. Financial implications and practice guidelines. Diabetes Care 1992;15(Suppl 1):29-31.
96. Reddy M, Gill SS, Rochon PA. Preventing pressure ulcers: a systematic review. JAMA 2006;296:974-84. (Pubitemid 44285374)